Evidence-Based Mortality Projections in Fatal Cardiac Claims

In fatal clinical negligence claims, the assessment of life expectancy and the attribution of cause of death require a structured approach to clinical evidence that meets the rigorous demands of civil litigation. For legal practitioners, the challenge lies in distinguishing between the progression of underlying cardiac disease and a death potentially accelerated by an alleged breach of duty. Robust expert evidence must navigate the complex interplay between established risk factors, such as ischaemic burden or valvular progression, and the acute index events that are the subject of the claim.

Clinical Methodology in Causation Analysis

Establishing causation in cardiology-related deaths often involves a counterfactual analysis, testing the claimant’s position against the backdrop of the deceased’s pre-existing cardiovascular status. Expert opinion addresses whether, but for the alleged breach, the deceased would have survived the index event, and for what probable duration. This requires a granular review of the clinical record, including historical investigations such as echocardiographic assessment of left ventricular ejection fraction, coronary angiography, and previous risk stratification. Where the case involves structural heart disease or rhythm disturbances, an expert may utilise specialist consultancy regarding cardiac pathology to quantify the natural history of the condition. The expert’s role is to provide a reasoned opinion on the most likely clinical trajectory, acknowledging the inherent uncertainties in biological systems while ensuring the opinion remains grounded in peer-reviewed clinical frameworks.

The Application of the Bolam/Bolitho Framework

In cases of alleged diagnostic or management error, the standard of care is assessed via the Bolam test, as modified by Bolitho v City and Hackney HA [1998]. For the court to accept an expert’s assertion that a particular course of action was acceptable, the opinion must be capable of withstanding logical analysis. In mortality projections, this means that where an expert argues that a different diagnostic pathway would have altered the outcome, they must demonstrate that this would have led to a medically accepted intervention with a defined statistical benefit. The expert’s duty under CPR 35.3 is to the court, and this duty requires the objective evaluation of mortality risks even when those risks suggest a poor prognosis regardless of the management provided.

Distinguishing Expert Procedure: CPR Part 35

Procedural efficiency in cardiac claims relies on the correct application of the Civil Procedure Rules (CPR). Under CPR 35.7, the court may direct the appointment of a Single Joint Expert (SJE) to provide an impartial assessment of complex technical issues, with instructions governed by CPR 35.8. This is distinct from the process described in CPR 35.12, where parties instruct their own experts who may be directed to meet to identify areas of agreement and disagreement. In mortality projection disputes, these joint statements can assist the court in narrowing the issues, ensuring that the tribunal is not tasked with reconciling disparate, non-comparable methodologies for life expectancy calculation. Experts must be prepared to articulate the evidence base for their projections, whether they rely on population-based actuarial data or specific disease-based progression models.

Considerations in Mortality Projections

• Comorbidities: Mortality estimates that account for non-cardiac conditions, such as chronic kidney disease or metabolic syndrome, generally provide a more balanced projection than those focusing solely on cardiac markers.
• Prognostic Uncertainty: Causation is determined on the balance of probabilities. Experts should differentiate between clinical mortality, which is a statistical likelihood, and the specific event outcomes within the litigation framework.
• Diagnostic Interpretation: Disputes frequently arise regarding the timing and interpretation of biomarkers. Experts should distinguish between a symptomatic presentation requiring urgent intervention and incidental findings, applying current definitions of cardiac events to the specific timeline of the claim.
• Consent and Procedure: In elective procedures, the discussion of material risks as described in the Montgomery standard is as significant as technical execution. Mortality projections may be secondary to whether the procedure was indicated or if the patient was appropriately advised of alternative outcomes.

For solicitors, the objective is to obtain an expert report that is clinically forensic. Instructing experts with active subspecialty practice allows for an accurate application of established frameworks to the specific facts of the case. A precise, evidence-based approach to mortality ensures that quantum is calculated on a sound foundation, reducing the scope for dispute on the valuation of the claim.